Search Results for 'Biomaterials'

One of Mayo’s biggest employers, Allergan in Westport, is to create 20 new jobs. These will be added to the almost 800 jobs already at the Westport facility when it begins manufacture of Allergan’s newest medical technology, SeriScaffold which represents a $10 million investment at the Westport site.

In a major boost for regenerative medicine research in Ireland, Minister for Enterprise, Trade, and Innovation, Batt O’Keeffe announced this week the funding of almost €10 million for the Regenerative Medicine Institute (REMEDI) at NUI Galway.

Research and development projects in the field of medical technologies at NUI Galway are to receive an investment boost of €900,000 over the next two years from Covidien, one of the world’s leading suppliers of healthcare products.

Epidermolysis Bullosa (EB) is a genetic skin disease where blistering occurs on the skin and on internal linings such as the mouth and the intestines. It is believed to occur in an estimated one out of every 50,000 births worldwide. Those affected are often described as ‘butterfly children’ as their skin is as fragile as a butterfly’s wings.

It is clear to most people in Galway that the medical device industry plays a fundamental role in the economic fabric of the city. Indeed, while visitors to the city may be surprised to overhear terms like ‘stent’, ‘biomedical device’ or ‘catheter’ rising out of countless conversations on Shop Street on Saturday afternoon, it is hardly surprising to locals who know that more than 6,000 are employed in the medical device sector in Galway. Indeed, if we look at the number of people indirectly employed this figure rises to about 10,000. No doubt every Galwegian knows someone who works in the medical device industry or a related industry.

Professor Larry Egan, Interim Director of the Health Research Board (HRB) Clinical Research Facility, Galway has welcomed the announcement that €7.5m in capital funding is being provided for the construction of a new Clinical Research Facility on the grounds of University Hospital Galway.

Professor Larry Egan, Interim Director of the Health Research Board (HRB) Clinical Research Facility, Galway has welcomed the announcement that €7.5m in capital funding is being provided for the construction of a new Clinical Research Facility on the grounds of University Hospital Galway.

Proxy Biomedical Ltd, a leading innovator in the development of biomaterials for regenerative medicine, this week officially opened its new manufacturing premises in an Údarás na Gaeltachta facility in An Spidéal.